Terazosin hydrochloride en es it fr

Terazosin hydrochloride Brand names, Terazosin hydrochloride Analogs

Terazosin hydrochloride Brand Names Mixture

  • No information avaliable

Terazosin hydrochloride Chemical_Formula

C19H25N5O4

Terazosin hydrochloride RX_link

http://www.rxlist.com/cgi/generic/teraz.htm

Terazosin hydrochloride fda sheet

Terazosin_hydrochloride FDA

Terazosin hydrochloride msds (material safety sheet)

Terazosin hydrochloride Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Terazosin hydrochloride Molecular Weight

387.433 g/mol

Terazosin hydrochloride Melting Point

273 oC

Terazosin hydrochloride H2O Solubility

29.7mg/mL

Terazosin hydrochloride State

Solid

Terazosin hydrochloride LogP

0.875

Terazosin hydrochloride Dosage Forms

Tablet

Terazosin hydrochloride Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Terazosin hydrochloride Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Terazosin hydrochloride Absorption

Essentially completely absorbed in man (90% bioavailability).

Terazosin hydrochloride side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Terazosin hydrochloride Patient Information

Terazosin hydrochloride Organisms Affected

Humans and other mammals